E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/15/2006 in the Prospect News Biotech Daily.

Provalis shareholders approve company liquidation

By Elaine Rigoli

Tampa, Fla., Sept. 15 - Provalis plc's shareholders have approved the voluntary liquidation of the company and said the cancellation of the listing of the shares will be effective Monday.

Following the passing of the resolutions, the joint liquidators have now been appointed and Peter Woodford, Alan Aikman and Lee Greenbury have resigned as directors of the company.

The Deeside, England, diagnostics company previously agreed to sell its medical diagnostics business for effective consideration of £1.6 million through the sale of the entire issued share capital of its subsidiary, PB Diagnostics Ltd., to Bio-Metrics Ltd., a subsidiary of Bio-Rad Laboratories, Inc.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.